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 Chapter 20 
 Study of Neurotoxic Intracellular Calcium Signalling 
Triggered by Amyloids 
 Carlos  Villalobos ,  Erica  Caballero ,  Sara  Sanz-Blasco , 
and  Lucía  Núñez  
 Abstract 
 Neurotoxicity in Alzheimer’s disease (AD) is associated to dishomeostasis of intracellular Ca 2+ induced by 
amyloid  β peptide (A β ) species. Understanding of the effects of A β on intracellular Ca 2+ homeostasis 
requires preparation of the different A β assemblies including oligomers and fi brils and the testing of their 
effects on cytosolic and mitochondrial Ca 2+ in neurons. Procedures for cerebellar granule cell culture, 
preparation of A β species as well as fl uorescence and bioluminescence imaging of cytosolic and mitochondrial 
Ca 2+ in neurons are described. 
 Key words:  Amyloid  β peptide ,  Oligomers ,  Calcium ,  Bioluminescence imaging ,  Aequorin , 
 Alzheimer’s disease 
 
 Alzheimer’s disease (AD) is an aging-related neurodegenerative 
disorder associated to excess of amyloid  β peptide (A β ) production, 
an aberrant cleavage product of the amyloid precursor protein. AD 
has been also related to dis-homeostasis of intracellular Ca 2+ , an 
elusive issue that remains controversial  ( 1,  2 ) . A β species in AD 
brains are made of polypeptides of several lengths that may show 
different assemblies from monomers, dimmers, or other oligomers 
to the large fi brils forming macroscopic amyloid plaques, the hall-
marks of AD  ( 3 ) . A β species are toxic to neurons and contribute 
largely to neurodegeneration in AD. The mechanism of neurotox-
icity is under intense scrutiny and might differ among the several 
species  ( 4,  5 ) . Recent data show that A β 1–42 oligomers, the most 
likely neurotoxin in AD, but not fi brils, induce dramatic increases 
in cytosolic and mitochondrial Ca 2+ concentrations in primary 
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neurons that contribute to neurotoxicity  ( 6 ) . Here, we describe in 
detail the procedures for studying neurotoxic intracellular calcium 
signalling triggered by amyloids including neuron cell culture, 
preparation of different A β 1–42 species including oligomers and 
fi brils as well as the methodology to investigate the effects of these 
species on cytosolic and mitochondrial Ca 2+ in single neurons by 
fl uorescence imaging of fura2-loaded cells and bioluminescence 
imaging of cells expressing aequorin targeted to mitochondria. 
 
  1.  HEPES-buffered saline (HBS) contains 145 mM NaCl, 5 mM 
KCl,1 mM MgCl 2 , 1 mM CaCl 2 , 10 mM glucose, 10 mM 
sodium-HEPES, pH 7.4. 
  2.  Ham’s F12 nutrient mixture is made solving (powder) 
Dulbecco’s Modifi ed Eagle’s Medium (DMEM, Sigma-Aldrich 
Ref. 7777-10X1L) in 900 ml of double-distilled, sterile water. 
Then, 6 g HEPES and 336 mg NaHCO 3 are added to the mix. 
The solution is stirred and the pH adjusted to 7.42 using 4 N 
NaOH. Sterile water is added to a fi nal volume of 1 l. Solution 
is then fi ltered in sterile conditions using Nalgene fi lters 
(Nalgene Labwere, Roskilde, Denmark) and saturated with 
CO 2 in sterile conditions before use. 
  3.  Hank’s medium is prepared mixing 85 ml of HBSS medium 
(Gibco Ref. 041-04170) with 15 ml of 4% bovine serum 
albumin (BSA, prepared previously solving 4 g of BSA in 
100 ml of HBSS). 
  4.  Solutions for cell dissociation: Dispase II (neutral protease) 
from  Bacillus polymyxa , grade II (Roche). 
  5.  Culture medium is made of DMEM (Gibco Ref. 41966-029) 
containing 4,500 mg/l glucose and 2 mM  L -glutamine, fetal 
bovine serum (FBS, 10%), horse serum (HS, 5%), penicillin 
100 U/ml, and streptomycin 100  μ g/ml. All these items are 
from Invitrogen, Barcelona, Spain. 
  6.  Sato’s medium  ( 7 ) is made of DMEM (Gibco Ref. 41966-
029) containing also 0.5% HS, 5  μ g/ml insulin, 100  μ g/ml 
BSA, 16  μ g/ml putrescine, 30 nM Se 2+ , 60 ng/ml progesterone, 
0.4  μ g/ml tiroxine, 0.3  μ g/ml tri-iodotironine, and 5 mg/ml 
holo-transferrin. 
  7.  Poly- L -lysine-coated coverslips are prepared by placing 12-mm 
glass sterilized coverslips into a 0.01 mg/ml solution of 
poly- L -lysine (Sigma-Aldrich, Madrid, Spain). Treat for 15 min 
and then wash the coverslips twice with water and air-dry for 
30–60 min under sterile conditions. 
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  8.  Multidish four wells for 12-mm glass coverslips are from Nunc 
(Ref. 176740), Rochester, NY, USA. 
  9.  Amaxa Nucleofector and solution kit for neurons (Lonza 
Cologne, Germany). 
 Amyloid  β peptide (1-42) is from Bachem AG (Bubendorf, 
Switzerland). 
 Solvents HCl and hexafl uoroisopropanol (HFIP) are from Sigma-
Aldrich. 
 Dimethyl sulfoxide (DMSO, Sigma-Aldrich). 
 DMEM F12 without phenol red (Gibco, Ref. 21041-025). 
 DMEM without phenol red (Lonza, Ref. 12-917F). 
 Speed Vac SPD111V (Thermo Electron Corporation, Marietta, 
OH, USA). 
  1.  HBS containing 145 mM NaCl, 5 mM KCl,1 mM MgCl 2 , 
1 mM CaCl 2 , 10 mM glucose, 10 mM sodium-HEPES, 
pH 7.4. 
  2.  Fura2/AM (Invitrogen, F1201, 1 mg). Stock solutions are 
made in DMSO at a concentration of 2 mM and stored at 
−20°C. 
  3.  Digitonin (Sigma-Aldrich, D5628) dissolved at 100  μ M in 
HBS containing 10 mM CaCl 2 instead 1 mM. Stock solution 
can be prepared at 10 mM in DMSO. 
  4.  mGA plasmid. The mGA probe contain a mutated, low-affi nity 
aequorin targeted to mitochondria and a GFP sequence to help 
select transfected neurons for bioluminescence imaging  ( 8 ) . 
  5.  Coelenterazine  n (Invitrogen, Ref. C6776). Stock solution is 
dissolved in methanol at 200  μ M, aliquoted in 30  μ l portions 
in Eppendorf tubes in ice and gassed briefl y with N 2 before 
closing the tubes. Wrap with aluminum foil and store at −80°C 
for up to 6 months. 
  6.  Zeiss Axiovert S100 TV (Carl Zeiss, Inc., Gottingen, Germany) 
inverted microscope equipped with a Zeiss Fluar 40x, 1.3 NA 
oil objective, a Xenon XBO75 fl uorescence excitation lamp or 
a XCITE illumination system (EXFO, Ontario, Canada), a 
excitation fi lter wheel (Sutter Instrument Company, Novato, 
CA, USA) with band pass fi lters for fura2 excitation (340 and 
380 nm) and a fura2 dichroic mirror. 
  7.  ORCA ER fl uorescence camera (Hamamatsu) mounted in the 
frontal or the lateral port of the microscope and handled by the 
Hamamatsu Aquacosmos software. 
  8.  Hamamatsu VIM photon-counting ICCD camera (C2400-35) 
mounted in the bottom port of the microscope. Argus Image 
 2.2.  Preparation of 
Amyloid  b Peptide 
Species
 2.3.  Fluorescence 
and Bioluminescence 
Imaging
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
C. Villalobos et al.
Processor and M4314 image intensifi er controller (Hamamatsu) 
are handled by the Aquacosmos software. 
  9.  Cell perfusion system for living cells mounted in a PH-3 
thermostated platform for open 12-mm glass coverslips using 
an 8-line gravity-driven perfusion system equipped with pinch 
valves (VC-8 valve controller) and solutions heated using an 
SH-27B inline heating system. All the above components are 
from Warner Instruments, Hamden, CT, USA. 
  10.  Home-made, light-proof box covering the imaging set up. 
Size is about 100 × 100 × 100 cm. They are also available from 
commercial sources (see Hamamatsu Photonics, Hamamatsu, 
Japan). 
 
  1.  Cerebellar granule cells are obtained from 5 to 7-day-old 
Wistar rat pups as reported previously  ( 9 ) . Animals are sacri-
fi ced by decapitation and the head is quickly washed in fresh 
HBS medium devoid of Ca 2+ and glucose. 
  2.  The skull is open to extract the brain that is washed quickly 
with Ham’s F12 medium before dissecting the cerebellum. 
  3.  Meninges are carefully removed and cerebellum is then washed 
with Hank’s medium without Ca 2+ or Mg 2+ at 4°C. 
  4.  Cerebellum is then cut in small pieces (about 2 mm) and 
incubated with Hank’s medium without Ca 2+ or Mg 2+ but 
containing now dispase II (5 mg/ml) for 30 min at 37°C with 
discontinuous stirring every 5–10 min. 
  5.  Tissue pieces are then dispersed using a silanized Pasteur 
pipette. 
  6.  Dispersed tissue is allowed to rest to help debris removal. 
Supernatant-containing dispersed cells is placed into centrifuge 
tubes containing 7 ml of DMEM and cell suspension is then 
centrifuged at 200 ×  g for 5 min. 
  7.  The cell pellet is suspended in 1 ml of DMEM and then centri-
fuged again. Supernatant is removed and the new pellet is 
suspended again in 1 ml of DMEM containing now 10% 
horse serum. 
  8.  At this point, cell density is estimated using a Neubauer counting 
chamber and medium is added to get a cell concentration of 
1 × 10 6 cells/ml. At this point, 60  μ l drops of cell suspension 
are plated on 12-mm glass coverslips previously coated with 
poli- L -lysine (0.01 mg/ml) and located inside the four wells 
multidish plaque. Cells are allowed to attach to the coverslips 
inside a cell incubator (37°C, 10% CO 2 ) for about 1 h. 
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  9.  Once cells are attached, 500  μ l of DMEM containing 
4,500 mg/ml glucose, 10% FBS, 5% horse serum, and antibiotics 
(penicillin, 100 U/ml and streptomicine, 100  μ g/ml) are 
added to the four wells. 
  10.  After 24 h, plating medium was exchanged for Sato’s medium 
 ( 7 ) containing 5% HS to avoid excess proliferation of glia  ( 9 ) . 
Cells are kept in the incubator for 3–5 days before imaging 
experiments. 
  1.  Preparation of A β 1–42 assemblies is carried out as described by 
Klein  ( 10 ) . A β 1–42 (Bachem AG) is initially dissolved to 1 mM 
in hexafl uoroisopropanol and aliquoted in sterile, non-siliconated 
microcentrifuge tubes. The peptide was incubated 60 min at 
room temperature and then in ice for 5–10 min. 
  2.  The eppendorf containing the peptide solution is maintained 
open overnight to allow evaporation of HFIP. 
  3.  Hexafl uoroisopropanol (HFIP) is then fully removed under 
vacuum in a speed vac. (10 min), and the peptide fi lm was 
stored desiccated at −80°C. 
  4.  For the aggregation protocol, the peptide was fi rst solved in 
dry DMSO at a concentration of 5 mM and treated differently 
for preparation of oligomers and fi brils (Fig.  1 ). 
  5.  For preparation of oligomers, DMEM without phenol red was 
added to bring the peptide to a fi nal concentration of 100  μ M 
and incubated at 4°C for 24 h. The preparation was then 
centrifuged at 14,000 ×  g for 10 min at 4°C to remove insoluble 
aggregates (protofi brils and fi brils) and the supernatants 
containing soluble A β 1–42 oligomers were transferred to clean 
tubes and stored at −20°C (see Note 1). 
  6.  For preparation of fi brils, the peptide resuspended in DMSO at 
5 mM concentration was diluted in 10 mM HCl to bring the 
peptide to a fi nal concentration of 100  μ M and incubated at 
37°C for 24 h (see Note 1). 
  1.  Coverslips containing cultured cerebellar granule cells were 
washed with HBS medium and incubated in the dark in the 
same medium containing 4  μ M fura2/AM  ( 11 ) for 60–90 min 
at room temperature. 
  2.  Coverslips are then placed on a Warner PH-3 thermostated 
platform for open 12-mm glass coverslips (total volume about 
500  μ l) on the stage of an inverted microscope (Zeiss Axiovert 
S100 TV) and perfused continuously with heated (37°C) HBS 
using a Warner 8-line gravity-driven perfusion system equipped 
with pinch valves (Warner VC-8 valve controller) and a Warner 
SH-27B inline heating system (see Note 2). 
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 Fig. 1.  Preparation of A β oligomers and fi brils. A β 1–42 (Bachem AG, 1 mg) was dissolved at 1 mM in hexafl uoroisopropanol 
(HFIP) and incubated fi rst 60 min at RT and then 10 min in ice. Then, the peptide was incubated overnight with the eppendorf’s 
cup open. HFIP was removed under vacuum in a speed vac., (10 min); the peptide fi lm can be stored desiccated at −20°C 
at this point. The peptide fi lm is solved in DMSO at 5 mM and treated differently for preparation of oligomers ( right ) and 
fi brils ( left ). For oligomers ( right ), DMEM F-12 without phenol red is added to bring the peptide to 100  μ M and incubated 
at 4°C for 24 h. Then, preparation is centrifuged (14,000 ×  g , 10 min, 4°C) and the supernatant-containing A β 1–42 oligomers 
is transferred to clean non-siliconated, eppendorf tubes and stored at −20°C until use. For fi brils ( left  ), the peptide (5 mM) 
in DMSO is solved in 10 mM HCl to bring the peptide to a fi nal concentration of 100  μ M and incubated at 37°C for 24 h. 
Then, samples are stored at −20°C. 
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  3.  Cells are epi-illuminated alternately at 340 and 380 nm using 
band pass fi lters located on the excitation fi lter wheel. Light 
emitted above 520 nm at both excitation lights was fi ltered by 
the fura-2 dichroic mirror, collected every 5–10 s with a 40×, 
1.4 NA, oil objective and recorded with the Hamamatsu Orca 
ER camera (Fig.  2 ). 
 Fig. 2.  Equipment for imaging of cytosolic and mitochondrial calcium. The system set up 
for imaging is built on an inverted microscope (Zeiss Axiovert S100 TV). For fl uorescence 
excitation, a X-cite excitation lamp (1) provides excitation light that passes through fi lters 
(340 and 380 nm) contained in a fi lter wheel (2) and refl ected by a dichroic mirror (3) 
before illuminating cells located in the heated stage of the microscope (4). Fura2 fl uores-
cence (>520 nm) is collected by a Zeiss Fluar 40x, 1.3 NA oil objective, passes through 
the dichoric mirror (3) but is refl ected by a further mirror (5) before being captured by a 
frontal or lateral-port located, Hamamatsu Orca ER digital camera (6) handled by the 
camera controller and the aquacosmos software in a computer system (7). For biolumi-
nescence imaging, photonic emissions coming from the living cells pass through the least 
possible optic devices (dichroic mirror is removed from the pathway) including only an 
analyzer lens and a tube lent. Light travels through the microscope’s bottom port via 
adaptor without lent and reaches the Hamamatsu C2400-35 ICCD intensifi er (8) con-
trolled by the M431 image intensifi er controller, before is captured by a Hamamatsu CCD 
video camera (9). Signal goes through an Argus image processor and a JVC RGB monitor 
and is fi nally processed by the same computer system (7). The entire microscope must be 
covered by a light-proof box (10) to avoid light interference. Cells are perfused using a 
gravity-fed system (Warner). Solutions are prewarmed at 37°C (11) and driven through 
silicon tubes (12) by a valve-controlled perfusion system (13). All tubes converge by a 
manifold system (14) into one silicon tube that goes through an on-line heating system 
(15) before getting to the stage. Medium is continuously removed by another silicon tube 
attached on the platform and aspirated by vacuum pump (16) to the waste bottle (17). 
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  4.  A background image is also captured at both excitation 
wavelengths with the shutter closed. During recordings, cells 
are perfused either with heated (37°C) control HBS or HBS 
containing test substances at a fl ow of 5 ml/min. This fl ow 
ensures that the medium bathing the cells is exchanged about 
ten times in less than 1 min. 
  5.  At the end of the recording period, the complete sequences of 
images taken at 340 and 380 nm excitation light are stored in 
the computer for further analysis. 
  6.  Using the Aquacosmos software, background images are 
subtracted and the resulting images are ratioed pixel by pixel to 
obtain a sequence of ratio images. Ratio images are coded in 
pseudocolor to better appreciate changes in Ca 2+ concentrations. 
Perfusion of cerebellar granule cells with oligomers prepared 
from A β 1-42 induced rather dramatic increases in these ratios 
(Fig.  3 ), whereas no effect is induced by fi brils (data not shown). 
  7.  For quantitative analysis of individual cells, regions of interest 
(ROIs) are drawn on individual cells and all ratio values corre-
sponding to all pixels within each ROI are averaged for each 
image resulting in a recording of ratio values for individual 
ROIs (cells). 
  8.  Recorded ratio values are converted into Ca 2+ concentration 
values using the algorithm developed by Grynkiewicz et al. 
 ( 11 ) (see Note 3). 
Ab1-42 Oligomers 
1 min
2000
0
500
1000
1500
[C
a2+
] cy
t (n
M)
control
+ Ab1-42
 Fig. 3.  A β 1-42 oligomers elicit increases in cytosolic Ca 2+ in neurons. Cerebellar granule 
cells were cultured, loaded with fura2 and subjected to fura2 imaging. Pictures show 
pseudocolor images (Ratio 340/380) of granule cells before ( left ) and after stimulation 
with A β 1-42 oligomers. Warmer colors refl ect increased cytosolic Ca 2+ concentration. 
Recordings show cytosolic Ca 2+ concentrations taken every 5 s in three individual cells. 
Perfused A β 1-42 oligomers increase cytosolic Ca 2+ concentrations in all three neurons. 
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  1.  Coverslips containing cerebellar granule cells are transfected 
with the mGA plasmid (see Note 4) using a Nucleofector II ® 
device and the VPG-1003 transfection kit (Amaxa Biosystems, 
Cologne, Germany). Neurons are cultured for 24 h after 
transfection to allow effi cient expression and targeting of 
the probe. 
  2.  The coverslips containing the cells expressing the apoaequorins 
are transferred to a 4-well plate containing 0.20 ml of HBS. 
Then, 1  μ l of coelenterazine  n is added and gently mixed. 
Finally, the plate is incubated for 1–2 h at room temperature in 
the dark. 
  3.  Bioluminescence imaging was carried out as described previ-
ously  ( 12,  13 ) . Coverslips are placed on the stage of the biolu-
minescence microscope (Zeiss Axioverti S100 TV) into a 
perfusion chamber thermostated to 37°C and perfused 
continuously with prewarmed HBS at a rate of 5 ml/ml. The 
cells are examined for GFP fl uorescence using the FITC fi lters 
and the microscopic fi eld selected. A typical fi eld may contain 
4-8 transfected cells. A GFP fl uorescence image (Fig.  4 ) is 
captured with the help of the Hamamatsu C2400-35 ICCD 
camera with the sensitivity set to a minimum (0) and located in 
the bottom port of the microscope (see Note 5). 
  4.  After turning off the excitation lamp, a bright fi eld image of 
the same cells is captured using the same camera. 
  5.  Microscope light was turned off and the dark-box doors closed 
for complete darkness (see Note 6). Sensitivity of the intensi-
fi er is then set to maximum  ( 12 ) and photonic emission images 
are captured with the Hamamatsu VIM photon-counting cam-
era handled with an Argus-20 image processor and integrated 
every 10 s periods (Fig.  4 ). Total counts per region of interest 
may range between 2 × 10 3 and 2 × 10 5 for different cells. 
Background photonic emissions in regions of interest of simi-
lar size in nonexpressing cells are typically about 1 ± 1 count 
per second per typical cell area (about 2,000 pixels). 
  6.  Cells are perfused at selected periods with A β species at an 
estimated concentration of 1  μ M by using the perfusion sys-
tem. Alternatively, A β species can be provided as drops using 
an automatic pipette. 
  7.  Before ending the experiment, cells are perfused with HBS 
containing 0.1 mM digitonin and 10 mM CaCl 2 to permeate 
the cells and release all the remaining aequorin counts. These 
photonic emissions must be added up to estimate the total 
photonic emissions, a value required for calibration in Ca 2+ 
concentrations. Emission of all residual counts may take 
2–5 min from the time of lysis. The experiment is fi nished once 
aequorin photonic emissions cease. 
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 Fig. 4.  A β 1-42 oligomers induce mitochondrial Ca 2+ overload in neurons. Cerebellar granule 
cells were transfected with the low-affi nity, mitochondria-targeted aequorin fused to GFP, 
incubated with 1  μ M coelenterazine  n and subjected to bioluminescence imaging of 
[Ca 2+ ] mit . Pictures show the fl uorescence ( top , GFP fl uorescence) and accumulated photonic 
emissions ( bottom , Aequorin Bioluminescence) images of representative microscopic 
fi elds. Luminescence intensity is coded in pseudocolor. Top recordings show the release of 
photonic emissions (expressed as % of remaining counts) during recording in four individual 
cells. Perfusion with A β 1-42 oligomers (but no fi brils) released photonic emissions (thus, 
decreasing the % of remaining counts). Those values were used to calculate mitochondrial 
Ca 2+ concentrations ( bottom recordings). A β 1-42 oligomers promoted increases in mito-
chondrial Ca 2+ concentrations that reached even the mM level as previously reported  ( 6 ). 
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  8.  Bioluminescence images are fi nally stored in the computer with 
the bright fi eld and fl uorescence images captured before 
photon-counting imaging. 
  9.  Regions of interest (ROIs) are selected with the help of the 
Aquacosmos software by drawing circles around infected cells 
according to the fl uorescence and bright fi eld images captured 
at the beginning of the experiment (see Note 7). The same 
ROIs are pasted on every image of the sequence. Total photonic 
emissions in every ROI are computed with the Aquacosmos 
software to obtain the luminescence emission value ( L ) for 
each cell at each point in time. A few ROIs are drawn in regions 
devoid of cells to compute background luminescence. 
  10.  All the photonic emissions in the bioluminescence images, 
including the obtained after digitonin permeabilization, are 
added up using the Aquacosmos software to obtain a biolumi-
nescence image containing all the photonic emissions. The size 
of the ROI is adjusted to the area in which photons are emitted 
from each individual cell, which is usually somewhat larger 
than the size of the cell. Cells with overlapping of photonic 
emissions are excluded from the analysis. 
  11.  The luminescence values for every ROI at each time value ( L ) 
are computed and exported to a worksheet. Background lumi-
nescence is subtracted from each  L value. For every ROI, the 
total luminescence, Total( L ) was computed by adding up the 
values of all the images. Then, the following values were com-
puted for every time point ( t ):
  ● L : Luminescence emission at time  t 
 Sum(  ● L ) =  Σ L values from  t = 0 to  t 
  ● L TOTAL: Total luminescence remaining at time 
 t = Total( L ) − Sum( L ) 
 % Remaining luminescence: 100 ×   ● L TOTAL/Total( L ) 
  ● L / L TOTAL 
 [Ca  ● 2+ ] using the following algorithm:
  ×
− ×
2+ TR
R R
+( )+1
[Ca ] (in M units)= ,
( )
R R K
K R K
 
where  
=
× λ
(1/ )
TOTAL
,
nL
R
L
 
where  L is the luminescence emitted at the time of measurement 
and  L TOTAL is the addition of the counts present in the tissue 
at that time, estimated by integrating all the counts from the 
time of measurement until the release of all the residual lumines-
cence by lysis at the end of the experiment. Calculations were 
made using the constant values published elsewhere  ( 14 ) . 
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  1.  Characterization of amyloid  β preparations is beyond the scope 
of this chapter. However, the characterization is required to 
confi rm the species that are present in each preparation, their 
purity and actual concentrations. This characterization is not 
simple and may require a combination of several approaches 
including electron microscopy, amino acid analysis, PAGE-
SDS, and silver staining  ( 6 ) . 
  2.  Perfusion is very helpful during imaging not only to add and 
remove easily and quickly test solutions to the cell chamber but 
also to keep physiological conditions (37°C, or even CO 2 if 
required) thanks to the in-line heating system. Perfusion of 
expensive test solutions such as A β species may be, however, 
cost limiting. In those cases where perfusion is not available or 
convenient, A β can be provided by carefully adding a 250  μ l 
drop of 2×, A β -containing solution, to a half-fi lled chamber 
(about 250  μ l) and making a quick mix of solutions. In this 
case, it is best to keep the heating system off and make the 
experiment at room temperature to avoid changes in the com-
position of saline due to evaporation. 
  3.  Binding of Ca 2+ to fura2 changes fura2 fl uorescence according 
to the law of mass action  ( 11 ) : 
  2+ max
d
min
-
[Ca ]= ,
-
F F
K
F F
 
where  K d is the dissociation constant of the fura2–Ca 
2+ com-
plex (224 nM at 37°C),  F is the fl uorescence emission for each 
[Ca 2+ ],  F max is the fl uorescence emission when fura2 is saturated 
with Ca 2+ , and  F min is fl uorescence emission when fura2 is free 
of Ca 2+ . If we apply the above algorithm to both wavelengths 
and do the ratio, then we obtain the following algorithm:
  -
b
-
2+ max
d
min
[Ca ]= ,
R R
K
R R
 
where  R is the ratio of fl uorescence recordings obtained after 
exciting at 340 and 380 nm for a given [Ca 2+ ],  R max is the same 
ratio when fura2 is saturated with Ca 2+ , and  R min is the same 
ratio when fura2 is free of Ca 2+ . Finally,  b is the ratio of  F max / F min 
at 380 nm. This algorithm allows estimation of [Ca 2+ ] know-
ing the  R values at any point in time.  R max ,  R min , and  b values 
can be determined experimentally using fura2 solutions in the 
presence of saturating concentrations of Ca 2+ (HBS containing 
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1 mM Ca 2+ ) and in the absence of Ca 2+ free medium (HBS 
without added Ca 2+ and containing 5 mM EGTA).
  4.  The use of the fusion protein GFP–aequorin in the mGA plasmid 
has many advantages over the native aequorin. It allows direct 
visualization of the expressed protein under the fl uorescence 
microscope which is very convenient particularly when trans-
fection effi ciency is low. In addition, the protein is more stable, 
and it gives a higher quantum yield  ( 8 ) . 
  5.  The same set up for fl uorescence imaging can be used for 
bioluminescence imaging. We have the fl uorescence camera 
placed in the lateral port and the photon-counting camera in 
the bottom port. This confi guration avoids loosing of aequorin 
photonic emissions when the system is used in the biolumines-
cence imaging mode. Before photon counting, a GFP fl uores-
cence image of GFP and aequorin-transfected cells is captured 
with the bottom-port located, photon-counting camera and 
the sensitivity gain set to a minimum. Then, the dichroic-
containing box located in the light pathway is removed, the 
excitation light turned off, the dark-box doors are closed and 
the sensitivity gain is set to a maximum before starting biolu-
minescence imaging. 
  6.  Photon-counting cameras are extremely sensitive to any contam-
inating light. Accordingly, any light source inside the dark box 
must be turned off during photon counting. Putative light 
sources such as leads of different operators, even if they are 
outside the dark box, must be turned off. Some motorized 
microscopes have internal leads that may produce a light leak 
to the camera. 
  7.  Calibration of the recorded signals is dependent of the total 
amount of photonic emissions, including those released after 
cell permeabilization. If cell density is excessive or the amount 
of light emitted by some individual cells is too high, overlap 
between photonic emissions from different cells may happen 
and this could infl uence the calculations of Ca 2+ concentra-
tions. This can be avoided by optimizing expression effi ciency 
and/or by plating the cells at a proper density. 
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